1,989 material Form 8-K filings that 1,593 companies we cover made with the SEC in August 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
HF Sinclair agreed on August 2, 2026, to repurchase 2,375,000 shares of its common stock from REH Advisors Inc. at $89.41 per share, about $212 million in total, funded with cash on hand and expected to close on or around August 5, 2026. The company also raised its $1 billion share repurchase program by $15 million, effective July 31, 2026, leaving approximately $11 million of authorization remaining, which matters to shareholders because the purchase is a sizable use of cash and the shares will be held as treasury stock.
2,375,000 shares purchased from REH Advisors Inc. at $89.41 per share, about $212 million in total
Stock Purchase Agreement dated August 2, 2026; closing expected on or around August 5, 2026
This is the twenty-second privately negotiated transaction between the company and REH
Repurchase program increased by $15 million effective July 31, 2026; over $1 billion repurchased to date and about $11 million remaining
Provident Financial Services elected Michael E. Regan, a former FDIC senior bank examiner, to its board effective July 30, 2026, and appointed Diane Gigliotti as Senior Vice President and Chief Accounting Officer for the company and Provident Bank. The filing covers board and accounting leadership changes only and includes no financial results or guidance.
Michael E. Regan elected as a Class of 2028 director, with the Company and Bank boards each expanded from 12 to 13 directors
Regan appointed to the Audit Committee, Enterprise Risk Committee and Finance Committee
Diane Gigliotti, previously Bank Senior Vice President and Controller, takes the Chief Accounting Officer role and will report to CFO Adriano Duarte
Gigliotti's initial annual base salary is $310,000, with a target annual incentive of 30% and a target long-term incentive of 25% of base salary
Baxter International said its Interim Chief Financial Officer and Chief Accounting Officer and Controller, Anita Zielinski, will resign effective September 15, 2026, to join another company. The company said her decision was not due to any disagreement over operations, policies, practices, financial disclosures or accounting matters.
Anita Zielinski notified Baxter of her resignation on July 31, 2026.
Her resignation takes effect September 15, 2026.
She held the roles of Interim Chief Financial Officer and Senior Vice President, Chief Accounting Officer and Controller.
The filing states the departure was not related to any disagreement with management or the board.
Fluor Corporation increased its board from ten to eleven members effective August 4, 2026, and named retired Navy Admiral James F. Caldwell Jr. to the new seat. The board determined he is independent, and he joins the Audit and Governance Committees. The filing is a routine board addition and does not contain financial results or guidance.
Board size increased to eleven members effective August 4, 2026, per a July 30, 2026 board vote
Admiral James F. Caldwell Jr., U.S. Navy (retired), elected to fill the new seat effective August 4, 2026
Caldwell appointed to the Audit Committee and Governance Committee; board deemed him independent under NYSE standards
He receives standard non-employee director compensation and will sign the company's indemnification agreement
Martin Marietta announced on August 4, 2026 that it promoted Michael J. Petro to Executive Vice President and Chief Financial Officer. The filing sets out his new pay and severance terms, including a $750,000 base salary and a one-time restricted stock unit grant with a grant date value of $5,000,000.
Base salary of $750,000, with a target annual incentive of 100% of base salary
Target long-term incentive award of 260% of base salary
One-time restricted stock unit grant with a grant date value of $5,000,000, vesting ratably on the sixth, seventh and eighth anniversaries of the grant date
Severance of three times the sum of base salary and target bonus on termination without cause or for good reason, plus up to three years of medical and dental benefits
On August 4, 2026, Booz Allen Hamilton Inc., a wholly-owned subsidiary of Booz Allen Hamilton Holding Corporation, issued $700 million of 5.375% Senior Notes due 2030 and $500 million of 5.900% Senior Notes due 2034, a combined $1.2 billion in new debt. The parent company fully and unconditionally guarantees the notes on an unsecured and unsubordinated basis, so the new borrowing adds to the group's debt obligations that shareholders should weigh.
2030 notes: $700 million principal at 5.375%, maturing 2030
2034 notes: $500 million principal at 5.900%, maturing 2034
Notes sold under an automatic shelf registration effective July 24, 2026; closing occurred August 4, 2026
Underwriters' representatives include BofA Securities, J.P. Morgan, PNC Capital Markets and Truist Securities
Matthews International said CEO Joseph C. Bartolacci will retire as president and CEO and resign from the board. He will stay in both roles until a successor is appointed and starts, and will support the transition at least through January 1, 2027. The company said the decision is not the result of any dispute with the company, and the board has started a succession process.
Bartolacci informed the company of his decision on July 29, 2026; he has served as CEO since 2006 and with the company for nearly three decades.
He remains CEO and a board member until his successor starts, and will support the transition at least through January 1, 2027.
He will receive his prorated annual salary through January 1, 2027, and a prorated FY 2027 bonus at target level, subject to continued service through the retirement date.
The filing says the retirement is not the result of any dispute or disagreement with the company.
Dycom Industries appointed David Fallon and Michael Lenz to its Board of Directors on August 4, 2026, and increased the board from nine to eleven members. Both were determined to be independent and will stand for election at the 2027 annual meeting, but they have not been assigned to any board committees.
Fallon previously served as Chief Financial Officer at Vertiv Holdings Co. (NYSE: VRT).
Lenz most recently served as Executive Vice President and Interim Chief Financial Officer at Hexcel Corporation (NYSE: HXL) and previously as Executive Vice President and Chief Financial Officer at FedEx Corporation (NYSE: FDX).
Both directors will receive non-employee director compensation, prorated from their appointment date, subject to future Board action.
The Board increased its size from nine to eleven members.
On August 2, 2026, Integer Holdings agreed to be acquired by Armstrong Parent, Inc. and Armstrong Bidco, Inc., which are affiliates of investment funds managed by KKR. Under the merger agreement, each common share would convert into the right to receive $127 in cash, and Integer would survive as a wholly owned subsidiary of Parent. Shareholders would receive cash in place of their shares, and the deal depends on shareholder approval, antitrust clearance and other conditions.
Merger consideration of $127 in cash per common share, without interest, agreed on August 2, 2026
Closing requires approval by holders of a majority of outstanding common shares, plus Hart-Scott-Rodino and other antitrust clearances; the merger is not subject to a financing condition
Either party may terminate if the merger is not completed by May 2, 2027 (the Outside Date)
An equity commitment letter from KKR Core II Holding Company LLC and debt commitments from lenders are described as financing for the deal
Dave & Buster's CEO Tarun Lal retired effective August 3, 2026, to spend more time with his family in India. The Board appointed Chief Financial Officer Darin Harper as CEO and a board member on the same date, and Cory Hatton was named interim CFO while the company searches for a permanent CFO. The change puts a new CEO in charge and leaves the finance chief role temporarily filled.
Tarun Lal retired as CEO effective August 3, 2026, and will serve as an advisor through January 31, 2028, or an earlier date agreed with the company.
Darin Harper's employment terms include a $650,000 annual base salary, a target bonus of 100% of salary, and a one-time equity grant with a total value of $6,500,000.
Lal will receive a consulting fee of $85,833.33 per month during the consulting period.
Cory Hatton, Head of Entertainment Finance, Investor Relations & Treasurer, is interim CFO; Kevin Sheehan became Lead Independent Director and James P. Chambers became Chair of the Board, effective August 4, 2026.
Stagwell Inc. appointed Beth J. Kaplan to its board of directors effective July 31, 2026, after the board acted on July 29, 2026. The board determined she is independent under Nasdaq and SEC rules, and her term runs until the 2027 annual meeting of stockholders.
Beth J. Kaplan appointed director effective July 31, 2026; board action taken July 29, 2026
Term continues until the 2027 annual meeting of stockholders
Committee assignments to be made at a later date
As a non-employee director, she receives the same compensation as other non-employee directors, and has an Indemnification Agreement with the company
On July 29, 2026, J. Patrick O'Keefe notified Universal Corporation of his intention to retire as Vice President, Ingredients and Senior Vice President, Universal Ingredients, Inc. The company is working with an executive search firm to identify a successor, and Mr. O'Keefe will stay in his role until one is appointed. The filing does not name a successor or give a timeline for the appointment.
Retirement notice given July 29, 2026, as Vice President, Ingredients and Senior Vice President, Universal Ingredients, Inc.
Company is working with an executive search firm to identify a successor.
Mr. O'Keefe will remain in his current role until a successor is appointed, then provide transition support.
TXO Partners, L.P. announced that its general partner's board declared a $0.40 per common unit distribution for the quarter ended June 30, 2026. The company also posted an investor presentation on its website, which includes details on its 2026 capital program and Elm Coulee drilling in Montana.
Distribution of $0.40 per common unit for the quarter ended June 30, 2026.
Record date is August 14, 2026; payment date is August 21, 2026.
CEO Brent W. Clum said average lateral length of operated wells in 2026 is expected to approach 14,000 feet, versus roughly 10,000 feet in the 2025 program.
Presentation states 2026 full-year development costs are expected to be about $80 million.
Ingles Markets director Brenda S. Tudor notified the company on July 29, 2026, that she will resign from the Board and all committees, effective September 8, 2026, citing family health reasons and no disagreement with the company. The Board plans to appoint an additional independent member to the Audit Committee and elect a new director to fill the vacancy on or before her departure date.
Brenda S. Tudor notified the company of her resignation on July 29, 2026
Resignation takes effect September 8, 2026
Reason given is family health; filing states no disagreement with company operations, policies or practices
Board plans to add an independent member to the Audit Committee and fill the vacancy by the effective date
Burlington Stores said Executive Vice President and Chief Human Resources Officer Matthew Pasch will depart effective September 1, 2026, under a severance agreement dated July 31, 2026. John Pershing is expected to succeed him effective October 2026, which gives shareholders a named successor for a senior officer role.
Matthew Pasch's departure is effective September 1, 2026.
His severance agreement provides for pro-rata continued vesting of his 2024 performance-based RSU award, based on actual performance over the three-year period.
John Pershing is expected to become EVP and Chief Human Resources Officer in October 2026; he previously held CHRO roles at Barnes & Noble, Canadian Tire and Ascena Retail Group.
The full severance agreement will be filed as an exhibit to the Form 10-Q for the period ending August 1, 2026.
On August 4, 2026, Pacific Gas and Electric Company completed the sale of $1.7 billion in first mortgage bonds, under an underwriting agreement dated July 27, 2026. The filing is a debt financing disclosure and does not report earnings, guidance, or changes to operations.
2032 Bonds: $700 million aggregate principal, 5.250% coupon, due 2032
2036 Bonds: $1 billion aggregate principal, 5.850% coupon, due 2036
Sale completed August 4, 2026; underwriters include Barclays Capital, BMO Capital Markets, J.P. Morgan and SMBC Nikko
On August 3, 2026, PrimeEnergy amended its borrowing base agreement with Citibank, N.A., lowering the borrowing base from $115 million to $105 million. The company reported no outstanding borrowings under the credit facility as of March 31, 2026, and says it still has none as of the filing date.
Borrowing base reduced by $10 million, from $115 million to $105 million, under an amendment dated August 3, 2026
No outstanding borrowings under the credit facility as of March 31, 2026, and as of the filing date
Lender is Citibank, N.A.; amended agreement filed as Exhibit 10.22.6.5
RenovoRx announced it will take part in a JonesTrading key opinion leader webinar on pancreatic cancer and its TAMP technology platform on August 13, 2026, at 1:30 p.m. ET, with CEO Shaun Bagai as a speaker. The filing contains no financial results, guidance, or new clinical data, so it is an informational event announcement for shareholders.
Webinar is scheduled for Thursday, August 13, 2026, at 1:30 p.m. ET, moderated by JonesTrading analyst Justin Walsh.
Speakers include CEO Shaun Bagai and two oncologists, Dae Won Kim, MD, of Moffitt Cancer Center and Ravi Shridhar, MD, PhD, of AdventHealth Cancer Institute.
The release cites RenovoCath sales of approximately $1.1 million in 2025 and a record $563,000 in the first quarter of 2026.
A replay will be available on the company's investor relations website.
OnKure Therapeutics reported a second-quarter 2026 net loss of $15.3 million, or $0.31 per share, compared with $15.4 million, or $1.14 per share, a year earlier. Weighted average shares rose to 49,869,177 from 13,509,080, which accounts for most of the lower per-share loss. The company said its $176.4 million in cash, cash equivalents and marketable securities is expected to fund operations into 2029.
Q2 2026 net loss of $15.3 million vs. $15.4 million in Q2 2025; loss per share of $0.31 vs. $1.14
R&D expenses of $12.6 million, flat year over year; G&A expenses rose to $4.3 million from $3.7 million
Cash, cash equivalents and marketable securities of $176.4 million as of June 30, 2026, up from $59.1 million at December 31, 2025
IND submissions for OKI-355 and OKI-345 planned for the first half of 2027
On July 31, 2026, Celanese US Holdings, a subsidiary of Celanese, signed an amendment to its revolving credit agreement with Bank of America as administrative agent. The amendment raises the consolidated net leverage covenant to an initial 5.50:1.00 starting with the quarter ending March 31, 2027, and increases a debt basket for foreign and Chinese subsidiaries from $900 million to $1,050 million.
Amendment dated July 31, 2026 amends the credit agreement dated August 11, 2025
Net leverage covenant increases to an initial 5.50:1.00 from the quarter ending March 31, 2027 through maturity, with modified step-downs thereafter
Combined debt basket for foreign subsidiary acquisitions and Chinese subsidiary corporate purposes rises from $900 million to $1,050 million
Waste Connections completed an underwritten public offering on August 4, 2026, of C$300 million of 4.200% senior notes due 2033 and C$400 million of 4.550% senior notes due 2036. The notes are unsecured, rank equally with its other unsubordinated debt, and are not guaranteed by subsidiaries, so the company takes on new fixed-rate debt that it must repay with interest.
Total offering of C$700 million across two tranches: C$300 million of 2033 notes and C$400 million of 2036 notes
Interest is payable March 4 and September 4 each year, starting March 4, 2027
2033 notes mature September 4, 2033; 2036 notes mature September 4, 2036
Notes are registered under a Form S-3 and sold in Canada under a Canadian Offering Memorandum
AT&T closed on August 3, 2026 the sale of five series of Global Notes in euros and pounds sterling under a July 27, 2026 underwriting agreement. The filing is an administrative step to file exhibits for incorporation into an existing registration statement, and it discloses no change in earnings or guidance.
Notes sold: €1.0 billion due 2030, €1.25 billion due 2034, €1.0 billion due 2038, €850 million due 2045, and £550 million due 2052
Underwriting agreement dated July 27, 2026, with Barclays, Citigroup, Goldman Sachs and Wells Fargo as representatives
Notes were issued under a 2013 indenture with The Bank of New York Mellon Trust Company, N.A., as trustee
Consumers Energy Company issued and sold $450 million of 4.900% first mortgage bonds due 2031 and $450 million of 6.100% first mortgage bonds due 2056, a total of $900 million, on August 4, 2026. The filing says the net proceeds will go to general corporate purposes, and the 8-K mainly files the offering documents as exhibits to the shelf registration statement.
Two tranches totaling $900 million: $450 million at 4.900% due 2031 and $450 million at 6.100% due 2056
Terms set in an underwriting agreement dated July 30, 2026, with BofA Securities, Goldman Sachs & Co. LLC and six other underwriters named
Estimated offering expenses total $1,725,003, including $124,003 in SEC registration fees and $1,377,000 in rating agency fees
Net proceeds are earmarked for general corporate purposes
Steel Dynamics said CEO Mark Millett will retire as chief executive on January 1, 2027, and become Executive Chairman. CFO Theresa Wagler will succeed him as President and CEO on that date, and Richard Poinsatte will become CFO. The filing also lists operating and technology role changes effective September 1, 2026, and the board expanded from seven to eight members.
Theresa Wagler, EVP and CFO since 2007, becomes President and CEO effective January 1, 2027, and joins the board immediately
Mark Millett retires as CEO effective January 1, 2027, and becomes Executive Chairman
Richard Poinsatte becomes EVP and CFO effective January 1, 2027
Barry Schneider becomes EVP and Chief Technology Officer effective September 1, 2026
Pinnacle West Capital entered an Equity Distribution Agreement on August 4, 2026 allowing it to sell up to $500 million of common stock through a group of banks, including forward sale arrangements. The company says net proceeds would fund investment in Arizona Public Service Company for capital expenditures, commercial paper repayment and general corporate purposes. Shareholders may face dilution if shares are sold, but the filing does not say whether or when any sales will occur.
Aggregate gross sales price capped at $500 million, including any forward sale agreements
Managers and forward sellers may receive commissions of up to 1% of gross sales price
Proceeds intended for Arizona Public Service Company capital expenditures, commercial paper repayment and general corporate purposes
Shares registered under Form S-3 (Registration No. 333-277448); prospectus supplement dated August 4, 2026
Johnson & Johnson said Executive Vice President Jennifer Taubert will retire as Worldwide Chairman, Innovative Medicine, effective September 1, 2026, after more than 21 years with the company. Tom Cavanaugh, currently Company Group Chairman, North America, Innovative Medicine, will succeed her and join the Executive Committee on the same date. The company says Innovative Medicine grew to more than $60 billion in annual revenue under Taubert's leadership, but the filing gives no figures on how the transition will affect results.
Jennifer Taubert retires as EVP, Worldwide Chairman, Innovative Medicine, effective September 1, 2026
Tom Cavanaugh succeeds her and joins the Executive Committee effective September 1, 2026
Cavanaugh joined Johnson & Johnson in 2017 and previously spent nearly 15 years at Celgene
Taubert had a tenure of over 21 years at Johnson & Johnson; the unit she led had more than $60 billion in annual revenue
Evolus Europe amended its December 20, 2023 license and distribution agreement with Symatese Aesthetics, adding Canada and Australia/New Zealand as territories and granting Evolus exclusive rights to commercialize the Estyme injectable hyaluronic acid gel line there. The filing gives Evolus payments of €920,000 upfront and up to an additional €1.38 million on regulatory approvals, with commercialization expected in 2028, so the financial commitment is modest and the effect on results depends on approvals and sales that are not yet quantified.
Upfront signing payments of €920,000, plus up to €1.38 million more on receipt of certain regulatory approvals
Initial term of 15 years for each new territory from first regulatory approval, with automatic five-year renewals
Symatese is responsible, at its expense, for development and regulatory work needed in the new territories
Commercialization in Canada, Australia and New Zealand is expected in 2028; the company cites a total addressable market of about $500 million annually for neurotoxins and dermal fillers in these markets
On July 31, 2026, Griffon closed the sale of its AMES Australasia business to a joint venture led by the business's management with Australian financial investors. Griffon received $181 million in cash, a PIK note with a face value of AUD 69.3 million (USD $48.6 million), and a 49% indirect equity interest, and it used proceeds to repay the remaining $285 million of Term Loan B.
Cash received at closing: AUD 258 million (USD $181 million)
PIK note from the joint venture: AUD 69.3 million (USD $48.6 million), 10% annual interest, capitalized, maturing up to 10 years from issuance
Griffon holds 49%; Simon Hupfeld, the Executive Chairman of the business, leads and controls the remaining 51%
Griffon repaid the remaining $285 million of Term Loan B on July 31, 2026
MARA Holdings said directors Barbara Humpton and Georges Antoun resigned from the board effective July 31, 2026, citing personal reasons and no disagreements with the company. On August 1, 2026, the board appointed Craig Hart and Nancy Novak to fill the two vacancies, with Hart also joining the Risk and Audit Committee. The board will still have seven directors, six of whom are independent, so the change is administrative and does not signal a shift in financial results.
Barbara Humpton and Georges Antoun resigned from the board, effective July 31, 2026, for personal reasons.
Craig Hart and Nancy Novak were appointed directors on August 1, 2026, effective immediately.
Hart succeeds Antoun on the Risk and Audit Committee; the board will have seven directors, six independent.
Hart is a Senior Portfolio Manager at Avenue Capital Group; Novak previously was Chief Innovation Officer of Compass Datacenters.
McDonald's appointed Skye Anderson, a company executive with more than 26 years of service, as President of McDonald's USA effective August 4, 2026. She succeeds Joe Erlinger, who has decided to leave the company after more than two decades, and who will advise through early 2027.
Skye Anderson appointed President, McDonald's USA, effective August 4, 2026; she will oversee nearly 14,000 U.S. restaurants
Anderson succeeds Joe Erlinger, who is leaving the company after almost seven years leading the U.S. business
Erlinger will serve as an advisor until early 2027 to support the transition
Anderson had returned to McDonald's USA as Chief Operating Officer earlier this year as part of a planned transition
On August 3, 2026, CAMP4 Therapeutics completed the second closing of its private placement, selling common shares and pre-funded warrants for approximately $50.1 million in gross proceeds before placement agent fees and other expenses. The closing followed Australian clearance to start a Phase 1/2 trial of CMP-002 and a Price Threshold Waiver under the original agreement. The new shares and warrants add to the company's share count, and the company says the proceeds will support CMP-002 and its early-stage pipeline.
Second closing on August 3, 2026 issued 10,756,498 shares at $1.53 and 21,925,368 pre-funded warrants at $1.5299 each.
Gross proceeds of approximately $50.1 million, before placement agent fees and other expenses.
Also sold 39,306 shares at $1.65 to certain management, directors and co-founders.
Closing was triggered after July 2026 clearance for the CMP-002 Phase 1/2 trial in Australia; securities are unregistered and subject to a Registration Rights Agreement dated September 9, 2025.
Certara, Inc. said its President and Chief Commercial Officer, Leif E. Pedersen, left that role effective August 1, 2026. He will stay on as a Senior Advisor to help with transition matters until December 31, 2026, when his employment is set to end without cause and he becomes eligible for severance under his existing agreement and the company's Executive Officer Severance Policy.
Departure from President and Chief Commercial Officer role effective August 1, 2026
Senior Advisor role for transition matters through December 31, 2026
Employment to be terminated without cause on December 31, 2026, with severance benefits
Severance details are incorporated by reference from the April 3, 2026 proxy statement
Granite Construction entered unwind agreements on August 4, 2026, to terminate in full the capped call transactions tied to its 3.75% Convertible Senior Notes due 2028, which it had called for redemption. The counterparties will pay cash based on the company's share price over a five-day period starting August 4, 2026, but the filing does not state an amount. The company expects to use the proceeds with cash on hand to settle note conversions on August 12, 2026.
Unwind agreements signed August 4, 2026, with certain financial institutions (Capped Call Counterparties)
Cash settlement amounts will be based on the volume-weighted average share price over a five-day period beginning August 4, 2026; no amount is stated
Settlement expected on or about August 11, 2026; note conversions expected to be settled August 12, 2026
Underlying notes: $273.7 million aggregate principal of 3.75% Convertible Senior Notes due 2028, called for redemption as previously disclosed on May 19, 2026
ADI Global Distribution completed its separation from Resideo on August 3, 2026, when Resideo shareholders received ADI common stock and ADI began trading on the NYSE under the symbol ADIG. To fund a $900 million cash dividend paid to Resideo, ADI's subsidiary issued $400 million of 7.125% senior notes due 2034 and ADI borrowed a $600 million term loan under a credit agreement that also includes a $500 million revolving facility. The filing shows ADI is now an independent company with a new debt load, a new eight-member board, and a large preferred-equity stake held by the CD&R Group.
Resideo shareholders received one ADI common share for every two Resideo shares held as of the July 20, 2026 record date; fractional shares were sold and the cash proceeds distributed.
ADI issued $400 million of 7.125% senior notes due 2034 and funded a $600 million term loan, with the notes proceeds released from escrow on August 3, 2026.
ADI paid a one-time $900 million cash dividend to Resideo as partial consideration for assets and liabilities transferred to ADI.
The CD&R Group will hold shares and ADI preferred stock representing about 19.69% of total voting power on an as-converted basis, with two directors designable.
Resideo completed the spin-off of ADI Global Distribution on August 3, 2026, and ADI began regular-way trading on the New York Stock Exchange as ADIG on August 4, 2026. Resideo says it is now a pure-play building technologies company, and its shares continue to trade as REZI. The separation also included a $900 million repayment of Term Loan B debt and a change in leadership, with Tom Surran serving as both CEO and principal financial officer.
Holders of record on July 20, 2026 received one ADI common share for every two Resideo common shares held
Resideo repaid $900 million of Term Loan B principal and expects a further repayment of approximately $200 million by the end of its third fiscal quarter
Resideo Series A Cumulative Convertible Participating Preferred Stock was reduced to 350,000 shares outstanding, with the conversion price adjusted to $18.844
Jay Geldmacher retired as CEO and Thomas Surran became CEO effective August 3, 2026
American Strategic Investment Co. (NYSE: NYC) said it will release its financial results for the second quarter ended June 30, 2026, on Wednesday, August 12, 2026, before the New York Stock Exchange opens. The company will not hold a webcast or conference call, and the release itself contains no financial results.
Second quarter 2026 results will be released on Wednesday, August 12, 2026, before the NYSE open.
The company will not host a webcast or conference call for the release.
Forward-looking statements cite the company's ability to return to compliance with NYSE continued listing standards and its election to terminate its REIT status.
Quanta Services agreed on August 3, 2026 to sell $2.0 billion of senior notes in an underwritten public offering, with coupons of 4.850% to 5.550%. The company plans to use the net proceeds for general corporate purposes, including repaying commercial paper and senior credit facility borrowings, and the offering is expected to close on August 6, 2026. The filing does not report the effect on the company's debt totals or interest costs.
$500 million of 4.850% notes due 2029, priced at 99.950% of face value
$750 million of 5.300% notes due 2033, priced at 99.757% of face value
$750 million of 5.550% notes due 2036, priced at 99.696% of face value
Closing expected August 6, 2026; proceeds to repay commercial paper and senior credit facility borrowings
On August 4, 2026, Prologis agreed to acquire SEGRO plc through a recommended offer implemented as a UK court-sanctioned scheme of arrangement. SEGRO shareholders would receive 0.0920 Prologis common shares per SEGRO share, with an option to take part of the consideration in cash, and the deal values SEGRO at about £14.0 billion. For Prologis shareholders, the issuance would dilute existing holders: SEGRO shareholders would hold about 8.9% of the combined group if the cash alternative is fully taken up, or about 11.5% if no cash elections are made.
Terms: 0.0920 New Prologis Shares per SEGRO ordinary share; partial cash alternative capped at about £3.5 billion, with a basic entitlement of 258 pence cash plus 0.0690 shares
Ownership: SEGRO holders would own about 8.9% of the combined group if cash is fully taken up, or about 11.5% with no cash elections
Financing: Term Loan Credit Agreement of up to £3,575,000,000 with JPMorgan Chase Bank, N.A. as administrative agent, maturing one year after initial borrowing with two one-year extension options
Timing: completion expected in the first half of 2027, subject to shareholder, court, antitrust and exchange listing conditions
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.